Literature DB >> 34702645

[Salvage radiotherapy after prostatectomy - what do do in case of elevated post operative PSA or macroscopic relapse?]

I Latorzeff1, G Ploussard2, U Schick3, N Benziane4, D Pasquier5, P Sargos4.   

Abstract

The management of the postoperative biological relapse of prostate cancer is most often based on salvage radiotherapy (RT) and a variable duration of hormone therapy (HT) in addition. The indications for RT±HT become more consensual for the adjuvant postoperative situation or in the event of a rising PSA level after a period where an undetectable PSA level was achieved. On the other hand, in the event of detectable PSA immediately postoperatively or in the event of a biological recurrence with macroscopic relapse in the prostate bed seen on conventional imaging assessment, the treatment options are still being evaluated. This article will describe these 2 situations and their current management but also will come through assessments with the contribution of modern imaging and new treatment options in terms of RT dose and RT±HT combination.
Copyright © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer de la prostate; Clinical trials; Detectable PSA; Essais cliniques; Macroscopic relapse; PSA détectable; Prostate cancer; Radiothérapie de rattrapage; Rechute macroscopique; Salvage radiation therapy

Mesh:

Substances:

Year:  2021        PMID: 34702645     DOI: 10.1016/j.canrad.2021.08.017

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  1 in total

1.  Editorial: Post Operative Radiation Treatment for Prostate Cancer.

Authors:  I Latorzeff; P Sargos; F Saad
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.